# Safety and Efficacy Study of Ciprofloxacin for Inhalation in Patients With Non-Cystic Fibrosis Bronchiectasis "ORBIT-1"

> **NCT00889967** · PHASE2 · COMPLETED · sponsor: **Aradigm Corporation** · enrollment: 95 (actual)

## Conditions studied

- Non-Cystic Fibrosis Bronchiectasis

## Interventions

- **DRUG:** Ciprofloxacin for Inhalation
- **DRUG:** Ciprofloxacin for Inhalation
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00889967
- **Lead sponsor:** Aradigm Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-02
- **Primary completion:** 2011-04
- **Final completion:** 2011-06
- **Target enrollment:** 95 (ACTUAL)
- **Last updated:** 2017-01-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00889967

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00889967, "Safety and Efficacy Study of Ciprofloxacin for Inhalation in Patients With Non-Cystic Fibrosis Bronchiectasis "ORBIT-1"". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00889967. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*